Oncotarget · 2017 · 15 citations · 34 references
MedicineMolecular BiologyOncologyBreast OncologyCarcinogenesisMolecular OncologyCancer Cell SignalingEpigenetic Regulation In CancerHormone SignalingHormone-related CarcinogenesisOncogenic Signaling PathwaysSignal Transduction In CancerAndrogen Receptor ExpressionAndrogen Receptor RegulationBreast Cancer EpigeneticsBreast Cancer HistologyBreast Cancer HistopathologyBreast Cancer ProgressionTumor Initiating CellsTumor-initiating Cell Assays
// Wei Zhang 1, 2, 3, * , Xiaozhen Liu 1, * , Shan Liu 1 , Ying Qin 1 , Xiaoqi Tian 1 , Fengting Niu 1 , Han Liu 1 , Ning Liu 4 and Yun Niu 1 1 Department of Breast Cancer Pathology and Research, National Clinical Cancer Research Center, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Tianjin, China 2 Department of Anatomy and Histology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China 3 Laboratory of Epigenetics and Tumorigenesis, Tianjin Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, China 4 Department of Pathology, Baodi Clinical Institute of Tianjin Medical University, Tianjin, China * These authors contributed equally to this work Correspondence to: Yun Niu, email: yunniu2000@126.com Keywords: breast cancer; androgen receptor; let-7a; tumor-initiating cells; CD44 + /24 -/low Received: October 19, 2017 Accepted: December 01, 2017 Published: December 08, 2017 ABSTRACT Androgen receptor (AR) is an important transcriptional factor, which is frequently expressed in invasive breast cancer and correlates patients’ prognosis. Our previous results indicate AR activation may increase let-7a expression in breast cancer cells, while let-7, a tumor suppressor, is reported to inhibit breast tumor-initiating cells (T-IC). The study aims to explore the effects of AR/let-7a signaling on breast T-IC and its regulatory mechanism. The results revealed that the expression of AR was significantly associated with let-7a and CD44 + /24 -/low especially in estrogen receptor positive (ER+) breast cancer tissues. The expression of AR and let-7a indicated better outcome, while patients with CD44 + /24 -/low phenotype had worse prognosis. AR activation induced by dihydrotestosterone (DHT) prevented cells proliferation, migration, invasion and self-renewal capacities in ER+ breast cancer cells, via transcriptional up-regulation of let-7a. In addition, AR could inhibit tumorigenesis and metastasis of ER+ breast cancer cells in the serial xenotranplanted animal models. Our data suggested that AR/let-7a signaling could inhibit the biological behavior of tumor-initiating cells (T-IC) in ER+AR+ breast cancers, which might become a new therapeutic target.
34
Prospective identification of tumorigenic breast cancer cells
Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández et al. · Proceedings of the National Academy of Sciences · 2003 · 10.4K citations · Full text
Medicine, Cell Biology, Oncology +11
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine O′Brien, Aaron Pollett, Steven Gallinger et al. · Nature · 2006 · 4.1K citations
Medicine, Cancer Biology, Oncology +11
RAS Is Regulated by the let-7 MicroRNA Family
Steven Johnson, Jaclyn Shingara, Mike Byrom et al. · Cell · 2005 · 3.7K citations · Full text
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Anne T. Collins, Paul A. Berry, Catherine Hyde et al. · Cancer Research · 2005 · 2.8K citations
Medicine, Cell Biology, Oncology +17
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Fengyan Yu, Herui Yao, Pengcheng Zhu et al. · Cell · 2007 · 1.9K citations · Full text